IL2 and chronic kidney disease: Alternatively, Foxp3+ Tregs can also be generated in vitro by IL-2, and TGF-β from naïve CD4+T cells [17], but little is known about the potential of peripheral Tregs from CKD patients as a source for an in vitro generated therapeutic cell product.